GSK plc
CIK: 0001131399Latest portfolio: $799.0M · Q4 2025
Holdings
15
Total Value
$799.0M
New Positions
15
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 18,245,691 | $310.2M | 38.82% | |
| 2 | CRSPCRISPR THERAPEUTICS AG | 3,220,627 | $168.9M | 21.14% | |
| 3 | BNTXBIONTECH SE | 889,824 | $84.7M | 10.60% | |
| 4 | VIRVIR BIOTECHNOLOGY INC | 8,550,954 | $51.6M | 6.45% | |
| 5 | LYELLYELL IMMUNOPHARMA INC | 1,512,659 | $46.6M | 5.83% | |
| 6 | IDYAIDEAYA BIOSCIENCES INC | 1,333,333 | $46.1M | 5.77% | |
| 7 | CYTKCYTOKINETICS INC | 340,434 | $21.6M | 2.71% | |
| 8 | SPROSPERO THERAPEUTICS INC | 9,190,606 | $21.4M | 2.68% | |
| 9 | FULCFULCRUM THERAPEUTICS INC | 1,785,714 | $20.2M | 2.53% | |
| 10 | BCYCBICYCLE THERAPEUTICS PLC | 1,529,561 | $10.8M | 1.36% | |
| 11 | CVRXCVRX INC | 1,007,583 | $7.2M | 0.90% | |
| 12 | NKTXNKARTA INC | 3,150,732 | $5.8M | 0.73% | |
| 13 | RGNXREGENXBIO INC | 271,456 | $3.9M | 0.49% | |
| 14 | SENSSENSEONICS HLDGS INC | 10,856 | $59K | 0.01% | |
| 15 | HBIOHARVARD BIOSCIENCE INC | 11,151 | $7K | 0.00% |
Sector Breakdown
Healthcare100.0% ($3.101761688898471e+57T)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 12, 2026 | $799.0M | 15 |
Fund Information
GSK plc is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $799.0M across 15 holdings. The largest position is WAVE LIFE SCIENCES LTD (WVE), representing 38.8% of the portfolio. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.